Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125730591 | 12573059 | 1 | I | 2005 | 20160712 | 20160720 | 20160720 | EXP | US-ASTRAZENECA-2016SE75936 | ASTRAZENECA | 47.00 | YR | F | Y | 69.90000 | KG | 20160720 | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125730591 | 12573059 | 1 | SS | LISINOPRIL. | LISINOPRIL | 1 | Oral | 0 | 5 | MG | TABLET | QD | |||||||
125730591 | 12573059 | 2 | SS | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | Oral | 50.0MG UNKNOWN | 0 | 50 | MG | ||||||||
125730591 | 12573059 | 3 | PS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 21366 | 20 | MG | TABLET | QD | |||||||
125730591 | 12573059 | 4 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 21366 | 20 | MG | TABLET | QD | |||||||
125730591 | 12573059 | 5 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 21366 | 20 | MG | TABLET | QD | |||||||
125730591 | 12573059 | 6 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | 81 | MG | QD | ||||||||
125730591 | 12573059 | 7 | C | GABAPENTIN. | GABAPENTIN | 1 | Oral | 100.0MG UNKNOWN | 0 | 100 | MG | ||||||||
125730591 | 12573059 | 8 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Oral | 0 | 25 | MG | QD | ||||||||
125730591 | 12573059 | 9 | C | ISOSORBIDE MONOHYDARTE | 2 | Oral | 0 | 30 | MG | QD | |||||||||
125730591 | 12573059 | 10 | C | ISOSORBIDE MONOHYDARTE | 2 | Oral | 0 | 30 | MG | QD | |||||||||
125730591 | 12573059 | 11 | C | FLUOXETINE | FLUOXETINE HYDROCHLORIDE | 1 | Oral | 0 | 60 | MG | QD | ||||||||
125730591 | 12573059 | 12 | C | TRAMADOL. | TRAMADOL | 1 | Oral | 50.0MG UNKNOWN | 0 | 50 | MG | ||||||||
125730591 | 12573059 | 13 | C | NITRO STAT | 2 | Sublingual | 0.4MG UNKNOWN | 0 | .4 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125730591 | 12573059 | 1 | Hypertension |
125730591 | 12573059 | 2 | Hypertension |
125730591 | 12573059 | 3 | Type IIa hyperlipidaemia |
125730591 | 12573059 | 4 | Chest pain |
125730591 | 12573059 | 5 | Arteriosclerosis |
125730591 | 12573059 | 7 | Neuropathy peripheral |
125730591 | 12573059 | 8 | Thyroid disorder |
125730591 | 12573059 | 9 | Chest pain |
125730591 | 12573059 | 10 | Prophylaxis |
125730591 | 12573059 | 11 | Depression |
125730591 | 12573059 | 12 | Pain |
125730591 | 12573059 | 13 | Chest pain |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125730591 | 12573059 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125730591 | 12573059 | Corrective lens user | |
125730591 | 12573059 | Device occlusion | |
125730591 | 12573059 | Intentional product misuse | |
125730591 | 12573059 | Intervertebral disc degeneration | |
125730591 | 12573059 | Myocardial infarction | |
125730591 | 12573059 | Nausea | |
125730591 | 12573059 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125730591 | 12573059 | 1 | 201602 | 0 | ||
125730591 | 12573059 | 3 | 200410 | 0 | ||
125730591 | 12573059 | 4 | 200410 | 0 | ||
125730591 | 12573059 | 5 | 200410 | 0 | ||
125730591 | 12573059 | 6 | 2010 | 0 | ||
125730591 | 12573059 | 7 | 2010 | 0 | ||
125730591 | 12573059 | 8 | 2013 | 0 | ||
125730591 | 12573059 | 11 | 2005 | 0 | ||
125730591 | 12573059 | 12 | 2004 | 0 | ||
125730591 | 12573059 | 13 | 201602 | 0 |